BERTRAM ANTHONY GRAVES

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease INDIANAPOLIS, IN NPI 1821186933

General Payments — all program years on this page

$20,469.23

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 473
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $838.76 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $838.7613

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $445.788
Boehringer Ingelheim Pharmaceuticals, Inc. $243.363
Novo Nordisk AS $124.261
Exact Sciences Corporation $25.361

By program year

Program yearAmountRecords
2018 $7,820.19143
2019 $3,813.15127
2020 $2,299.9076
2021 $1,490.2036
2022 $2,353.0443
2023 $1,853.9935
2024 $838.7613

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096661076 Novo Nordisk Inc $124.26 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104255607 AstraZeneca Pharmaceuticals LP $3.77 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104403991 AstraZeneca Pharmaceuticals LP $20.00 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104610080 AstraZeneca Pharmaceuticals LP $121.36 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104754536 AstraZeneca Pharmaceuticals LP $124.26 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104769582 AstraZeneca Pharmaceuticals LP $17.40 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105320952 AstraZeneca Pharmaceuticals LP $121.18 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105617641 AstraZeneca Pharmaceuticals LP $17.24 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105847329 AstraZeneca Pharmaceuticals LP $20.57 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114681571 Exact Sciences Corporation $25.36 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118168160 Boehringer Ingelheim Pharmaceuticals, Inc. $14.37 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118168162 Boehringer Ingelheim Pharmaceuticals, Inc. $112.89 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118168164 Boehringer Ingelheim Pharmaceuticals, Inc. $116.10 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.